Accumen Leadership Presenting at Inaugural Modern Healthcare Event
AN DIEGO, December 6, 2016 – Accumen, a clinical laboratory transformation company, will join leading industry experts and executives at Modern Healthcare’s Inaugural Leadership Symposium December 6 – 8, 2016. Innovative healthcare leaders will converge in Chicago, Illinois for this event and participate in thought leadership discussions. This year’s theme is “The Great Disruption” which will provide an environment for healthcare leaders to discuss new ideas and strategies that will allow organizations to thrive even in an environment of uncertainty and disruptive changes in healthcare policy.
Accumen CEO, Jeff Osborne will lead a discussion on Thursday morning titled “Policy + Application = Disruptive Change.” In an industry where some health systems are urged to outsource healthcare services to reduce costs, Osborne will share his passion for creating value through partnerships that allow health systems to achieve greater success while maintaining and developing the clinical laboratory within the system. Osborne will be joined by Senator Tom Daschle, Accumen Healthcare Advisory Lead.
During his presentation, Senator Daschle will draw on more than 20 years of experience in the Senate as a member of the House of Representatives as well as being co-chairman of national health task forces. Senator Daschle will offer his outlook on how Capitol Hill will approach healthcare reimbursement policy and delivery system reform under Republican control. His presentation will share how change in healthcare can often be met with resistance, but necessary to drive higher quality and patient service for health systems that innovate ideas and processes to achieve greater outcomes.
Accumen is committed to excellence and excited to partner with Modern Healthcare and other industry leaders that are striving to develop new ideas and solutions in an ever changing environment. Accumen leaders are prepared to provide insights about pertinent issues in healthcare and demonstrate the opportunity to optimize the clinical laboratory as an asset to create value and be used as an innovative and strategic approach to drive sustainability, revenue growth and patient outcomes.
Disclaimer: Accumen has no authority, responsibility or liability with respect to any clinical decisions made by – or in connection with – a provider’s laboratory, patient blood management, or other operations. Nothing herein and no aspect of any services provided by Accumen is intended – or shall be deemed – to subordinate, usurp or otherwise diminish any providers’ sole authority and discretion with respect to all clinical decision-making for its patients.
Accumen Inc. (along with its subsidiary, Chi Solutions Inc.), is a leading healthcare transformation company that provides end-to-end services and laboratory solutions in consulting, execution, utilization, and outreach support. By partnering with hospital and health system laboratories, we set new standards of performance in clinical laboratory management—driving higher quality, patient safety, better service, and unprecedented value. Accumen and Chi deliver results in laboratory operations, outreach, and patient blood management using a proven blueprint, innovative approach, and insight-driven proprietary technology to create healthier labs, healthier hospitals, and ultimately, healthier communities.
Accumen – Accelerating Breakthrough Performance®
Find out more at Accumen.com or ChiSolutionsInc.com
Cindy Judd, Chief Marketing and Communications Officer, Accumen
Phone: 847.404.9962 | Email: email@example.com
Accumen | 9246 Lightwave Avenue, Suite 320, San Diego, CA 92123 | P:858.777.8160